An interdisciplinary team in San Francisco uses acupressure, massage, counseling and other methods, as well as medicine, to help kids get relief from chronic pain. But such pediatric centers are rare.

A former official in the civil rights office says the unit seems afraid to offend U.S. Customs and Border Protection and ICE. Meanwhile, the complaints of abuses of families continue to pile up.

Certain high-cost drugs are straining state budgets. A new deal approved Wednesday allows Louisiana to spend a fixed amount for unlimited access to a costly cure. Other states may try to follow suit.

A quirk in the law gives an older opioid addiction treatment "orphan drug" status — and a period of exclusive market access. That may prevent some new therapies from reaching patients for years.

A federal agency issued a proposed rule Friday that rolls back Obama-era protections for transgender patients. Advocates for transgender people say the rule leaves them vulnerable to discrimination.

The Trump administration is revamping a rule governing discrimination in health-care setting, giving more leeway to providers who object to certain procedures for religious or conscience reasons.

The rule strengthens protections for health care providers who are unwilling to provide services like abortions. Critics say it could put women's health in danger.

Several 2020 Democratic candidates support Medicare for All, but what would that proposal look like in action?

The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.

As congressional lawmakers continue to turn up the heat on drugmakers, insurers and middlemen over the price of many medicines, one player says it will limit patients' share of the cost of insulin.

Lawmakers in the House and Senate are pressing companies to lower prices for insulin which is essential for many people with diabetes. The price is 10 times higher today than it was 20 years ago.

A federal judge has struck down a Medicaid work requirement in Arkansas and Kentucky. This is a major blow to the Trump administration's vision for the health insurance program for low-income people.

The Trump administration's shift in a major legal case against the Affordable Care Act could lead to the reversal of the expansive law and far-reaching effects on all Americans' health care.

Justice Department files notice that it agrees with a federal judge's ruling that the ACA should be thrown out. The administration had previously said it wanted only parts of the law invalidated.

The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better.

A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the "list" price.

Scott Gottlieb, head of the Food and Drug Administration, is resigning, effective next month. The reasons for his resignation are not yet clear, but it appears it was not requested by the White House.

In a surprise move, the Food and Drug Administration commissioner announced Tuesday he will resign from his position. Dr. Scott Gottlieb is widely viewed as an effective advocate of public health.

A new poll by the Kaiser Family Foundation shows that many people struggle to pay for medicines and that a majority of Americans would welcome a range of government interventions to lower prices.

The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.